Clinical Trials Logo

Filter by:
  • None
  • Page [1]
NCT ID: NCT02836574 Recruiting - Clinical trials for Diabetic Chronic Kidney Disease

A Study of Autologous Neo-Kidney Augmentâ„¢ (NKA) in Type 2 Diabetics With Chronic Kidney Disease

Start date: September 2016
Phase: Phase 2
Study type: Interventional

Multi-center, prospective, open-label, randomized, double-arm, deferred treatment study whereby eligible subjects will be randomized 1:1 after kidney biopsy to receive up to 2 injections of NKA (made from expanded autologous selected renal cells) into the biopsied kidney beginning as soon as NKA can be prepared, or the same series of up to 2 injections given 6 months (+4 weeks) apart beginning 12 months after renal biopsy

NCT ID: NCT02326935 Terminated - Multiple Sclerosis Clinical Trials

Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis

Start date: November 2014
Phase: Phase 1
Study type: Interventional

The intent of this clinical study is to answer the questions: 1) is the proposed treatment safe and 2) is treatment effective in improving the disease pathology of patients with Multiple Sclerosis and clinical outcomes.

NCT ID: NCT01960738 Completed - Injuries Clinical Trials

Common Recreational Diving Practices: A Randomized Control Trial Using Pre-Dive Checklist

Start date: June 2012
Phase: N/A
Study type: Interventional

To evaluate the efficacy of using a pre-dive checklist to prevent the incidence of diving mishaps in recreational divers.